在平行合成条件下深入研究了卤代(杂)芳烃磺酰卤胺化物的化学选择性,并确定了该方法的范围和局限性。结果表明, SN Ar反应性磺酰卤通常在第一步中进行磺酰胺合成;如果SN Ar活性中心具有足够的反应性,则第二次胺化也是可能的。相反,带有芳基化部分的磺酰氟在适当的控制下在后一个反应中心发生选择性转化。进一步的硫-氟化物交换(SuFEx)也是可能的,这对于某些磺酰卤类特别有价值。开发的两步并行双胺化方案提供了对 66.7 亿个化合物的合成可处理 REAL 型化学空间的访问(预期合成成功率 76%)。
The present invention relates to a compound of Formula (I) and the manufacturing method(s) thereof and the use thereof:
Formula (I)
wherein: Ar is a nitrogen-containing heteroaromatic ring group; X and Z are each a carbon atom, and so on; Y is CO, and so on; R
1
is a hydrogen atom, and so on; R
2
and R
3
are each a hydrogen atom, and so on; R
4
and R
5
are each a hydrogen atom, and so on; and the formula
is a single bond or a double bond.
According to the present invention, the compound of the present invention can provide Cdk4 and/or Cdk6 inhibitors for treating malignant tumors, because the compounds of the present invention exhibit a prominent growth inhibitory activity against tumor cells.